Intensive Care Icu clinical trials

Explore recruiting intensive care icu clinical trials.

Recruiting intensive care icu studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Intensive Care Icu trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PERi-operative Selective Decontamination of the Digestive tract to prevent severe infectious complications after Esophagectomy: a Randomized multicenter clinical trial in patients with primary resectable esophageal carcinoma (cT1-4, N0-3, M0)

Belgium, Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

A phase I/II, single arm, open label study of dasatinib as toxicity prophylaxis in the context of therapy with idecabtagene vicleucel in relapsed/refractory multiple myeloma

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A single-arm, multi-center, open-label Phase II study to determine the safety and efficacy of MB-CART2019.1 in pediatric subjects with relapsed/refractory (r/r) mature B-cell neoplasms who have relapsed after one or more prior therapies, including subjects with primary refractory disease

Germany, France, Italy, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

An open, randomized-controlled, multi-center phase-II clinical trial of individualized immunosuppression with intravenously administered donor modified immune cells (MIC) compared to standard-of-care in living donor kidney transplantation

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Intensive Care Icu trials by city

Intensive Care Icu in Toronto Intensive Care Icu in Vancouver Intensive Care Icu in Montreal Intensive Care Icu in Calgary Intensive Care Icu in Edmonton Intensive Care Icu in Ottawa Intensive Care Icu in Winnipeg Intensive Care Icu in Quebec City Intensive Care Icu in Hamilton Intensive Care Icu in Kitchener Intensive Care Icu in London Intensive Care Icu in Halifax Intensive Care Icu in New York Intensive Care Icu in Los Angeles Intensive Care Icu in Chicago Intensive Care Icu in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease